Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Thrombolytic Science Initiates Phase 2 Clinical Trial of its Novel Treatment Regimen for Ischemic Stroke

pharmaceutical-technologySeptember 06, 2018

Tag: Thrombolytic , Phase 2 , Ischemic Stroke

PharmaSources Customer Service